Frontline Therapy of Diffuse Large B Cell Lymphoma in Adults ( 18 to 60 Years Old): Randomisation Between High Dose Chemotherapy With Rituximab and CHOP 14 -Rituximab. Multicentric Randomised Prospective Trial.

Trial Profile

Frontline Therapy of Diffuse Large B Cell Lymphoma in Adults ( 18 to 60 Years Old): Randomisation Between High Dose Chemotherapy With Rituximab and CHOP 14 -Rituximab. Multicentric Randomised Prospective Trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Dec 2015

At a glance

  • Drugs Rituximab (Primary) ; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Methotrexate; Prednisone; Vincristine
  • Indications Diffuse large B cell lymphoma
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology
    • 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Nov 2012 Planned End Date (1 May 2013) added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top